These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 1693069
1. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witztum JL. Arteriosclerosis; 1990; 10(3):336-49. PubMed ID: 1693069 [Abstract] [Full Text] [Related]
3. Presence of LDL receptor-related protein/alpha 2-macroglobulin receptors in macrophages of atherosclerotic lesions from cholesterol-fed New Zealand and heterozygous Watanabe heritable hyperlipidemic rabbits. Daugherty A, Rateri DL. Arterioscler Thromb; 1994 Dec; 14(12):2017-24. PubMed ID: 7526898 [Abstract] [Full Text] [Related]
4. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Ylä-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053 [Abstract] [Full Text] [Related]
5. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Haberland ME, Fong D, Cheng L. Science; 1988 Jul 08; 241(4862):215-8. PubMed ID: 2455346 [Abstract] [Full Text] [Related]
6. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. Arterioscler Thromb; 1994 Apr 08; 14(4):605-16. PubMed ID: 7511933 [Abstract] [Full Text] [Related]
7. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits. O'Brien K, Nagano Y, Gown A, Kita T, Chait A. Arterioscler Thromb; 1991 Apr 08; 11(3):751-9. PubMed ID: 2029510 [Abstract] [Full Text] [Related]
8. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL. Arteriosclerosis; 1990 Apr 08; 10(3):325-35. PubMed ID: 1693068 [Abstract] [Full Text] [Related]
9. Autoradiographic analysis of the distribution of 125I-tyramine-cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit. Rosenfeld ME, Carew TE, von Hodenberg E, Pittman RC, Ross R, Steinberg D. Arterioscler Thromb; 1992 Aug 08; 12(8):985-95. PubMed ID: 1637798 [Abstract] [Full Text] [Related]
10. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL. J Clin Invest; 1991 Jan 08; 87(1):90-9. PubMed ID: 1985115 [Abstract] [Full Text] [Related]
11. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP. Arterioscler Thromb; 1993 Nov 08; 13(11):1689-99. PubMed ID: 7692957 [Abstract] [Full Text] [Related]
12. Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits. Bräsen JH, Häkkinen T, Malle E, Beisiegel U, Ylä-Herttuala S. Atherosclerosis; 2003 Jan 08; 166(1):13-21. PubMed ID: 12482546 [Abstract] [Full Text] [Related]
13. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Tsimikas S, Shortal BP, Witztum JL, Palinski W. Arterioscler Thromb Vasc Biol; 2000 Mar 08; 20(3):689-97. PubMed ID: 10712392 [Abstract] [Full Text] [Related]
14. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. J Clin Invest; 1996 Aug 01; 98(3):800-14. PubMed ID: 8698873 [Abstract] [Full Text] [Related]
15. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Boyd HC, Gown AM, Wolfbauer G, Chait A. Am J Pathol; 1989 Nov 01; 135(5):815-25. PubMed ID: 2683796 [Abstract] [Full Text] [Related]
16. Low density lipoprotein undergoes oxidative modification in vivo. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Proc Natl Acad Sci U S A; 1989 Feb 01; 86(4):1372-6. PubMed ID: 2465552 [Abstract] [Full Text] [Related]
17. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. J Clin Invest; 1997 Dec 01; 100(11):2680-90. PubMed ID: 9389731 [Abstract] [Full Text] [Related]
18. [Modified lipoproteins in atherosclerotic lesions of human aorta]. Wang X, Chen Q, Zhu Q. Zhonghua Bing Li Xue Za Zhi; 1998 Feb 01; 27(1):6-9. PubMed ID: 11244945 [Abstract] [Full Text] [Related]
19. Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein. Viita H, Närvänen O, Ylä-Herttuala S. Life Sci; 1999 Feb 01; 65(8):783-93. PubMed ID: 10466744 [Abstract] [Full Text] [Related]
20. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits. Shiomi M, Ito T, Tsukada T, Shiraishi M, Yata T. Arzneimittelforschung; 1998 Jun 01; 48(6):680-5. PubMed ID: 9689427 [Abstract] [Full Text] [Related] Page: [Next] [New Search]